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Abstract 
 
BACKGROUND 
Knowledge of the consumed amount of volatile anesthetic (VA) expressed in liquid agent is necessary 
to enable agent sparing dosing measures for billing purposes. The widespread Draeger Primus™ 
anesthesia machine displays in its logbook the amount of consumed VA at the end of each 
anesthesia, but the reliability of this parameter is yet unknown. 
 
OBJECTIVES 
To evaluate the precision and reliability of the inbuilt VA consumption display in Draeger Primus™ 
anaesthesia machines as compared with the gold standard of weighing the vaporizer before and after 
anesthesia. 
 
DESIGN 
Prospective comparative laboratory investigation. 
 
SETTING 
Operation rooms of a tertiary academic hospital. 
 
INTERVENTIONS 
Displayed VA consumptions have been compared with measured vaporiser weight differences before 
and after 10 sevoflurane and 10 desflurane anesthesias. 
 
MAIN OUTCOME MEASURES 
The average difference and spread of values between the predicted (displayed) and measured 
(control) values for VA consumption. 
 
RESULTS 
The displayed sevoflurane consumption overestimated the measured values by 4.3 ± 5.4 ml (7.6%). 
The displayed desflurane consumption underestimated the measured values by -3.5 ± 6.3 ml (6.2%). 
Nine from 10 sevoflurane pairs of values and all desflurane pairs of values were within ± 1.96 standard 
deviations. 
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CONCLUSION 
The displayed VA consumption calculations for sevoflurane and desflurane in the Draeger Primus™ 
are sufficiently reliable to estimate the pharmacoeconomic impact of VA delivery during inhalational 
anaesthesia. 
 
Key Words: consumption, volatile anaesthestics; pharmacoeconomics, sevoflurane, desflurane 
 
 
 
Introduction 
The consumption of volatile agents (VA) during anaesthesia and its pharmacoeconomic implications 
gain increasing attention.1, 2   Therefore the knowledge of the consumed amount of VA expressed in 
milliliters of liquid agent at the end of each case becomes relevant and represents useful information 
to apply agent sparing dosing measures. The knowledge of the VA consumption per case also might 
be used for billing. To satisfy this need, the popular anaesthesia machine Draeger Primus™ (Draeger 
AG & Co. KGaA, Lübeck, Germany) is equipped with an inbuilt ability to calculate the ongoing VA 
consumption which at the end of anaesthesia is displayed on the screen in a logbook.3, 4   This feature 
is not yet commonly used and should therefore be tested in clinical routine regarding its precision and 
reliability. 
The gold standard for VA consumption assessments for a specific period is to weigh the vaporiser 
before and after anaesthesia and to take the difference as the consumed amount. This method has 
been widely used for various anaesthesia related pharmacoeconomic investigations.5, 6  A certain 
technical problem derives from the necessity for a very precise balance that has a wide range of 
measurement. Usually the larger the measurement range, the less is the resolution for the differences 
between the measured objects. A customary vaporiser weighs up to 9 kg, while the differences found 
by the prevailing levels of the residual VA content varies in the range of a few grams. Besides, 
weighing of the vaporiser can be only adopted if this is planned in advance. Due to unavailability of 
such equipment as well as the necessity to plan the measurements individually in advance, this 
weighing method remains limited to a reduced number of cases. Therefore it is essential to know 
whether one can rely on the inbuilt calculation feature for VA consumption alone. This investigation 
has the purpose to evaluate the precision and reliability of the inbuilt VA consumption display in 
Draeger Primus™ anaesthesia machines. 
 
Material and Methods 
As being a purely laboratory investigation without interference with patients and/or personnel, there 
was no need for approval by the local Ethical Committee. We collected data from twenty anaesthesias 
of which ten were conducted with sevoflurane and ten with desflurane by using Draeger Primus™ 
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anesthesia respirators in 3 different operation rooms that are maintained according prescribed 
standards. Since patients from the involved cases were irrelevant for this investigation, their 
biometrical and clinical data was not recorded. The primary measured parameters were: weight of the 
vaporiser before and after anaesthesia and the displayed amount of consumed VA at the end of each 
procedure. As secondary parameters we documented duration and time course of the VA 
concentrations as they have been set at the vaporiser (Vol%), as well as of the fresh gas flow (FGF in 
L/min) used during each individual anaesthesia. From these secondary parameters we have deducted 
the average VA consumption per time unit and the actual costs that occurred for the used VA in 
absolute numbers and over time. 
To extract the correct amount of delivered/consumed VA by taking the weight of the vaporiser before 
and after anaesthesia, we divided the difference in grams by the specific weight of the involved VA, 
which is 1.53 g/ml for sevoflurane, and 1.47 g/ml for desflurane.7, 8    The accuracy (bias and variance) 
of the calculated VA consumption were determined by using Bland/Altman comparisons and linear 
correlations.9   For cost calculations the VA local Swiss market price per milliliter has been adopted, 
which in our case was at the time of the investigation 0.91 Euros (EUR)/ml for sevoflurane and 0.49 
EUR/ml for desflurane (based on a currency exchange rate of 1.0 EUR = 1.21 Swiss Francs). 
   
 
Results 
There was no interference between taking the measurements and the applied practice of anaesthesia. 
Therefore the collected data represent the unaffected daily routine of delivering general anaesthesia 
with VA in our department. When using sevoflurane the effective VA consumption resulted in 52.8 ± 
40.5 ml (mean and SD), while the Draeger Primus™ reading showed an overestimation of 4.3 ± 5.4 ml 
representing 7.6 ± 6.4% (Figure 1). When using desflurane, the effective VA consumption resulted in 
66.4 ± 25.7 ml (mean and SD), while the Primus reading showed an underestimation of -3.5 ± 6.3 ml 
representing -6.2 ± 9.1% (Figure 2). Nine from ten pairs of measurements for sevoflurane were 
located in-between ± 1.96 standard deviations (90%), while for desflurane all pairs of measurements 
were inside of ± 1.96 standard deviations (100%). The linear correlations between the predicted and 
measured consumption values resulted for sevoflurane with an R2 = 0.997 and for desflurane with an 
R2 = 0.947. 
In table 1 the used average settings for FGF and Vol% are displayed for both evaluated agents. 
Additionally, the VA consumption results, as well as the average time duration of the analysed 
anaesthesias and the final expenditure of fluid VA are listed (Table 1). The indicated VA costs over 
time as well as the absolute VA costs were calculated according recent market prices in Switzerland 
from October 2013.  . 
 
 
Discussion 
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According to the user manual, the Draeger Primus calculates VA consumption on a case by case 
basis. When ending anaesthesia and the ventilator is set to “standby” mode, the logbook presents the 
amount of delivered VA in milliliters, as well as its uptake into the patient. These two parameters are 
calculated from the recorded FGF courses as well as from the history of inspiratory and expiratory VA 
concentrations that were continuously taken from the gas sampling unit. The availability of both of 
these values allows an additional efficiency assessment of each anaesthesia case.10 The found 
overestimation of sevoflurane consumption by 7.6%, and the underestimation of desflurane 
consumption by -6.2 ± 9.1% can be best explained by the involvement of the respiratory gas sampling 
and monitoring system. The respiratory gas mix in the circuit is continuously sampled close to the 
tracheal tube. Therefore it cannot eliminate the distorting effects of filling the circuit system. Nor can 
deviations in the accuracy of the VA concentration sensors be avoided. In contrast to oxygen and 
carbon dioxide, the VA sensors are not subjected to automatic calibrations during each use, and 
therefore may present by time a certain drift. We consider the differences between predicted and 
measured VA consumption data as tolerable from clinical point of view. This is in accordance with 
similar to findings by Lockwood et al., who found their predicted values to lie within the 95% 
confidence intervals of the measured data. 11  When translating these average differences to resulting 
costs, we may have an error per case of about 4.73 CHF too much for sevoflurane and 2.10 CHF too 
low for desflurane, which should not pose serious objections against the reliability of the displayed 
values. However, due to the metrological background of these differences, one may not take the 
herein reported biases as constants. Instead, for each VA and anaesthesia workplace the mean bias 
has to be assessed by adopting the gold standard of the weighing method and then the found bias can 
be subtracted from the displayed readings. 
The average FGF when using desflurane is usually set lower then with sevoflurane. This may have 
two reasons: one is a widespread assumption that desflurane is more expensive than sevoflurane, 
which is true when the comparison is done with equipotent dosing thus increasing the users’ readiness 
to limit the FGF. A second reason is that in certain hospitals, there is prescribed a minimum FGF limit 
at either one or two liters per minute to avoid the accumulation of toxic compounds in the circle 
system. For desflurane it is unusual to set such limitations. This is the explanation why in our case the 
average FGF with desflurane was with 1.0 ± 0.3 l/min less than half than with sevoflurane at 2.1 ± 0.8 
l/min. The higher anaesthetic potence of sevoflurane permitted lower average inspiratory 
concentrations. The lower set FGF when using desflurane resulted in a more pronounced sparing 
effect for the liquid VA, and therefore the average costs over time were by 23% lower for desflurane. 
From our results we can conclude that the displayed VA consumption calculations for sevoflurane and 
desflurane are reasonably useful for estimation of the pharmacoeconomic impact of VA delivery during 
inhalational anaesthesia in a routine clinical setting. 
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Figures 
 
Figure 1 
Linear correlation and Bland/Altman analysis of pairs of measurements comparing the displayed 
(predicted) vs. control (measured) values from ten sevoflurane anaesthesias. The displayed values 
show a systematic overestimation (positive bias) by 7.6%. 
 
Figure 2 
Linear correlation and Bland/Altman analysis of pairs of measurements comparing the displayed 
(predicted) vs. control (measured) values from ten desflurane anaesthesias. The displayed values 
show a systematic underestimation (negative bias) by -6.2%. 
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Table 1 
 
Overview of delivery settings, duration and consumption for sevoflurane and desflurane (n = 20; mean 
± SD). 
 
 
Sevoflurane 
n = 10 
Desflurane 
n = 10 
Predicted VA consumption according the 
Draeger Primus™ display (ml) 52.8 ± 40.5 66.4 ± 25.7 
Measured VA consumption = control (ml) 48.5 ± 35.5 69.9 ± 22.9 
Difference to control (ml) 4.3 ± 5.4 -3.5 ± 6.3 
Difference to control (%) 7.6 ± 6.4 -6.2 ± 9.1 
Average VA concentration (Vol%) 2.1 ± 0.3 6.8 ± 1.7 
Average fresh gas flow (L/min) 2.1 ± 0.8 1.0 ± 0.3 
VA delivery duration (min) 217 ± 219 187 ± 66 
VA delivery over time (ml/h) 15.7 ± 5.6 22.1 ± 4.8 
VA costs (EUR) 44.46 ± 32.23 34.62 ± 11.32 
VA costs over time (EUR/h) 14.21 ± 5.04 10.90 ± 2.40 
VA = volatile agent 
 
